Our latest press releases, media appearances and news commentary.
Wellcome, in collaboration with MDC’s Psychiatry Consortium, launches funding call to support mental health drug innovators
New Board members bring diverse additional life science expertise to MDC
Funding awarded by UKRI to explore sustainable manufacturing of new targeted radiotherapy treatments that could improve patient outcomes
Medicines Discovery Catapult (MDC), a national Life Sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its Executive team with the appointment of a Chief Commercial Officer and its first Managing Director
Science and Health Ministers visited the site, accompanied by the first patient to be scanned using the cutting-edge technology, which will help unlock medical breakthroughs
Recognition of the CF AMR Syndicate’s impact this World AMR Awareness Week (18-24 November 2024)
PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects
Cross-sector initiative provides funding and support to accelerate new treatments for lung infections in CF
A partnership between ERS Genomics and Medicines Discovery Catapult will use CRISPR gene editing technology to transform the way medicines are developed
See how we can help support you with your next drug discovery project.
Speak to us